Key Insights

Highlights

Success Rate

94% trial completion (above average)

Published Results

183 trials with published results (16%)

Research Maturity

771 completed trials (66% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

4.5%

52 terminated out of 1167 trials

Success Rate

93.7%

+7.1% vs benchmark

Late-Stage Pipeline

22%

258 trials in Phase 3/4

Results Transparency

24%

183 of 771 completed with results

Key Signals

183 with results94% success52 terminated

Data Visualizations

Phase Distribution

810Total
Not Applicable (343)
Early P 1 (5)
P 1 (93)
P 2 (111)
P 3 (136)
P 4 (122)

Trial Status

Completed771
Unknown152
Recruiting86
Terminated52
Not Yet Recruiting35
Active Not Recruiting31

Trial Success Rate

93.7%

Benchmark: 86.5%

Based on 771 completed trials

Clinical Trials (1167)

Showing 20 of 20 trials
NCT07725081Completed

Osteoporosis Awareness in Chronic Spinal Cord Injury

NCT07154719Phase 4Active Not Recruiting

GLP-1R Actions on Muscle and the Skeleton

NCT05541432Not ApplicableCompletedPrimary

Finding the Optimal Resistance Training Intensity For Your Bones

NCT07325578Not ApplicableRecruiting

U.S. Prospective Evaluation of EPIONE Device for Percutaneous MSK Procedures

NCT07709247Not Yet RecruitingPrimary

Salivary Cytokines, MMP-8 and Dental Caries in Osteoporosis Patients

NCT04947722Not ApplicableActive Not Recruiting

The PREVENT Trial: a Pragmatic Cluster Randomized Controlled Trial of a Multifaceted Fracture Prevention Model for Long-term Care

NCT06059222Phase 4RecruitingPrimary

The Optimised Use of Romozosumab Study

NCT05060380Not ApplicableWithdrawn

Feasibility of a Novel Resistance Exercise in Individuals With Osteoporosis

NCT07677033RecruitingPrimary

Functional Muscle-Bone Incongruity Index (FKUI): A Prospective Observational Study

NCT05998863Phase 3WithdrawnPrimary

EffCaMgCit to Prevent Mineral Metabolism and Renal Complications of Chronic PPI Therapy

NCT07677072RecruitingPrimary

Can Serum Lumican Level Identify a Hidden Fragility Phenotype Beyond Bone Mineral Density in Postmenopausal Women?

NCT03924414Phase 4Completed

Trial of Parkinson's And Zoledronic Acid

NCT07665424Not ApplicableRecruitingPrimary

Safety and Efficacy Clinical Trial of the Vessel-X® Bone Filling Container System

NCT06938152Phase 4RecruitingPrimary

Effects of Cycle Therapy vs Sequential Therapy With Romosozumab and Denosumab in Postmenopausal Osteoporosis Patients

NCT07660484Not ApplicableNot Yet RecruitingPrimary

Link Between ASCorbemia Level and Osteoporosis

NCT02194660Active Not RecruitingPrimary

Fragility Fracture Liaison Service Project

NCT02194647Active Not RecruitingPrimary

Anti-osteoporosis Medication Monitoring and Management Service

NCT02800278Completed

Characteristics and Outcomes of Odontoid Fragility Fractures in Elderly

NCT02924545CompletedPrimary

Evaluation of Osteoporosis Support After a Severe Osteoporotic Fracture in Women Over 50 Years in University Hospital

NCT00821925Not ApplicableCompletedPrimary

Estimation of Osteoporosis' Prevalence in France: Pilot Study in the Department of the Alpes-Maritimes

Scroll to load more

Research Network

Activity Timeline